AJ
Akanksha Jain
About Akanksha Jain
Data last updated:
Akanksha Jain is a Director at Byrl Medical India Private Limited (since 2018) and Additional Director at Byrl Bioceuticals India Private Limited (since 2021). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.86 Cr; the largest is Byrl Medical India Private Limited at ₹1.66 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Byrl Medical India Private Limited U51909DL2009PTC194904 | Director | 12 Feb 2018 | 2009 | ₹1.66 Cr (FY 2023) | Active |
| Byrl Bioceuticals India Private Limited U15400DL2020PTC367927 | Additional Director | 02 Jun 2021 | 2020 | ₹20 Lakh (FY 2023) | Active |
Board colleagues of Akanksha Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitin Kumar Jain | 05131448 | Byrl Medical India Private Limited | Director |
| Ankur Goyal | 03192139 | Byrl Bioceuticals India Private Limited | Additional Director |
| Priyata Goyal | 08806388 | Byrl Bioceuticals India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akanksha Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akanksha Jain
Akanksha Jain currently holds 2 directorships: Byrl Medical India Private Limited (Director, since 12 Feb 2018, revenue ₹1.66 Cr (FY 2023)); Byrl Bioceuticals India Private Limited (Additional Director, since 02 Jun 2021, revenue ₹20 Lakh (FY 2023)).
Akanksha Jain was first appointed on 12 Feb 2018 as Director at Byrl Medical India Private Limited. The most recent appointment on record is 02 Jun 2021 at Byrl Bioceuticals India Private Limited.
The 2 current companies of Akanksha Jain that report revenue have a combined latest revenue of ₹1.86 Cr: Byrl Medical India Private Limited ₹1.66 Cr (FY 2023); Byrl Bioceuticals India Private Limited ₹20 Lakh (FY 2023).
The current boards of Akanksha Jain's companies include Nitin Kumar Jain (Byrl Medical India Private Limited), Ankur Goyal (Byrl Bioceuticals India Private Limited), Priyata Goyal (Byrl Bioceuticals India Private Limited).